Has Max Rosen received payments from drug or device companies?

Yes. Drug and device makers reported $188,338 in general payments to Max Rosen across 86 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Max Rosen did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Max Rosen come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Max Rosen

Diagnostic Radiology · Worcester, MANPI 1821031097

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $176,215 of the $188,338 with a category attached, or 93.6%. 6 manufacturers reported payments, led by Astrazeneca UK Limited at 59.5% of the total. Reporting peaked in 2023 at $61,760 and has fallen 78.6% since, to $13,200 in 2025. Among diagnostic radiology clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$188,338in general payments, 2019–2025

Across 86 payments — averaging $2189.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Astrazeneca UK Limited$112K
Merck$59K
Canon Medical Systems Corporation$12K
Canon Medical Research USA Inc.$5K
Aidoc Medical Ltd$106
Agfa Healthcare Corporation$17

$590,260in research payments, 2019–2025

Across 181 payments — averaging $3261.10 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Roche Products Limited$225K
Hoffmann-la Roche Limited$88K
AbbVie$87K
E.r. Squibb & Sons, L.L.C.$83K
Dr.reddy's Laboratories,inc.$67K
Genentech, Inc.$20K
plus $21K from 2 others

What the payments were for

Consulting fees$176,21594%
Speaking & faculty fees$12,0006%
Food & beverage$1230%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Astrazeneca UK Limited	34	$111,980
Merck	43	$59,435
Canon Medical Systems Corporation	5	$12,000
Canon Medical Research USA Inc.	2	$4,800
Aidoc Medical Ltd	1	$106
Agfa Healthcare Corporation	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

IMFINZI$111,980
KEYTRUDA$59,135
MRT-3020$4,800
Briefcase$106

How this compares

$188,338 in reported general payments places this provider in the 95th percentile of 1,206 diagnostic radiology providers in Massachusetts.

See all diagnostic radiology providers in Massachusetts →

Other diagnostic radiology in Worcester

Ajay WakhlooWorcester$1.5M
Alexander BankierWorcester$285K
Hesham MalikWorcester$46K
Gregg MillerBoston$1.8M
Ali GuermaziWest Roxbury$1.8M
Stephan AndersonBoston$1.6M
Ashraf ThabetBoston$1.4M
Mukesh HarisinghaniBoston$1.4M
Andrew KompelBoston$1.3M
Elaine IuanowBoston$590K

See the full list for Massachusetts →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →